Search by Drug Name or NDC

    NDC 17714-0133-50 ACETAMINOPHEN PM 500; 25 mg/1; mg/1 Details

    ACETAMINOPHEN PM 500; 25 mg/1; mg/1

    ACETAMINOPHEN PM is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Advance Pharmaceutical Inc.. The primary component is ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE.

    Product Information

    NDC 17714-0133
    Product ID 17714-133_60f41580-e074-faad-e053-2a91aa0a9076
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name ACETAMINOPHEN PM
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN PM
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 500; 25
    Active Ingredient Units mg/1; mg/1
    Substance Name ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
    Labeler Name Advance Pharmaceutical Inc.
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 17714-0133-50 (17714013350)

    NDC Package Code 17714-133-50
    Billing NDC 17714013350
    Package 50 TABLET in 1 BOTTLE (17714-133-50)
    Marketing Start Date 2002-01-09
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL b172226e-8f2a-4d9c-b7c7-dd737b90463a Details

    Revised: 12/2017